$NGTF
NightFood Holdings, Inc. Stock $ngtf

$ngtf Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-K Financial Statement

#000121390024113166 Filed on December 27, 2024

Income Statement

Concept	2024 Q4	2024 Q2	2024
Revenue			$89.27K
YoY Change			-33.11%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin			$175.2K
YoY Change			-67.72%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses			$1.078M
YoY Change			-44.54%
Operating Profit			-$988.7K
YoY Change			-45.38%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net			-$2.247M
YoY Change			-42.97%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings			-$3.236M
YoY Change			-43.73%
Net Earnings / Revenue			-3624.32%
Basic Earnings Per Share			-$0.03
Diluted Earnings Per Share			-$0.03
COMMON SHARES
Basic Shares Outstanding	129.0M shares	127.9M shares	126.5M shares
Diluted Shares Outstanding			126.5M shares

Balance Sheet

Concept	2024 Q4	2024 Q2	2024
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents		$148.3K
Short-Term Investments
Other Short-Term Assets		$107.2K
YoY Change		15.57%
Inventory		$25.81K
Prepaid Expenses		$1.206K
Receivables		$22.34K
Other Receivables
Total Short-Term Assets		$303.6K
YoY Change		-32.01%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill		$868.7K
YoY Change
Intangibles		$897.5K
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets		$1.339M
YoY Change
TOTAL ASSETS
Total Short-Term Assets		$303.6K
Total Long-Term Assets		$1.339M
Total Assets		$1.643M
YoY Change		267.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$624.7K
YoY Change		10.82%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities		$4.798M
YoY Change		118.27%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities		$4.798M
Total Long-Term Liabilities
Total Liabilities
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings		-$38.63M
YoY Change		10.4%
Common Stock		$128.9K
YoY Change		4.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		-$3.433M
YoY Change
Total Liabilities & Shareholders Equity		$1.643M
YoY Change		267.88%

Cashflow Statement

Concept	2024 Q4	2024 Q2	2024
OPERATING ACTIVITIES
Net Income			-$3.236M
YoY Change			-43.73%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities			-$710.0K
YoY Change			-41.48%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions			$150.0K
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities			-$447.9K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities			$1.253M
YoY Change			28.3%
NET CHANGE
Cash From Operating Activities			-$710.0K
Cash From Investing Activities			-$447.9K
Cash From Financing Activities			$1.253M
Net Change In Cash			$94.95K
YoY Change			-140.11%
FREE CASH FLOW
Cash From Operating Activities			-$710.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Entity File Number EntityFileNumber	000-55406
CY2024	dei	Entity Registrant Name EntityRegistrantName	NIGHTFOOD HOLDINGS, INC.
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3885019
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	520 White Plains Road
CY2024	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 500
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	Tarrytown
CY2024	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10591
CY2024	dei	Local Phone Number LocalPhoneNumber	866-291-7778)
CY2024	dei	City Area Code CityAreaCode	866
CY2024	dei	Security12b Title Security12bTitle	None
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Public Float EntityPublicFloat	1923511	usd
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	128957407	shares
CY2024	dei	Auditor Name AuditorName	Fruci & Associates II, PLLC
CY2024	dei	Auditor Location AuditorLocation	Spokane, Washington
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	148294	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53349	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	22337	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	29335	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	25808	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	107161	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	92726	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	303600	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	175410	usd
CY2024Q2	ngtf	Acquisition Costs Secured By Promissory Note AcquisitionCostsSecuredByPromissoryNote	441479	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	897542	usd
CY2024Q2	us-gaap	Assets Assets	1642621	usd
CY2023Q2	us-gaap	Assets Assets	175410	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1059251	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	594430	usd
CY2024Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3442987	usd
CY2023Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1549366	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4797748	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2245672	usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	278200	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	128907407	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	128907407	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	123587968	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	123587968	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	128907	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	123588	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	35064148	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	33112935	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-38626400	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-35306788	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-3433327	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-2070262	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1642621	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	175410	usd
CY2024	us-gaap	Revenues Revenues	89272	usd
CY2023	us-gaap	Revenues Revenues	133406	usd
CY2024	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	107395	usd
CY2023	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	277843	usd
CY2024	ngtf	Advertising And Promotional AdvertisingAndPromotional	56664	usd
CY2023	ngtf	Advertising And Promotional AdvertisingAndPromotional	144859	usd
CY2024	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	175190	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	838413	usd
CY2024	ngtf	Professional Fee ProfessionalFee	738690	usd
CY2023	ngtf	Professional Fee ProfessionalFee	941240	usd
CY2024	us-gaap	Operating Expenses OperatingExpenses	1077939	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	2202355	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-988667	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-2068949	usd
CY2024	us-gaap	Interest Income Other InterestIncomeOther	17599	usd
CY2024	us-gaap	Interest Expense Debt InterestExpenseDebt	432154	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	172769	usd
CY2024	ngtf	Interest Expense Financing Cost InterestExpenseFinancingCost	1082360	usd
CY2023	ngtf	Interest Expense Financing Cost InterestExpenseFinancingCost	2199273	usd
CY2024	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	638194	usd
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1265893	usd
CY2024	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-111730	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-361500	usd
CY2024	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2246839	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3999435	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-3235506	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6068384	usd
CY2024	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	84106	usd
CY2023	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1136946	usd
CY2024	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3319612	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7205330	usd
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	126540836	shares
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	126540836	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	103889833	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	103889833	shares
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	265576	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	77110	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	229729	usd
CY2023	ngtf	Common Stock Issued As Financing Cost CommonStockIssuedAsFinancingCost	104515	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	276066	usd
CY2023	ngtf	Common Stock Issued Under Forbearance And Exchange Agreement CommonStockIssuedUnderForbearanceAndExchangeAgreement	342000	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	91500	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	62850	usd
CY2023	ngtf	Warrants Issued As Financing Cost Associated With Convertible Notes WarrantsIssuedAsFinancingCostAssociatedWithConvertibleNotes	603689	usd
CY2023	ngtf	Adjustmentstoadditionalpaidincapital Warrantsissuedasfinancingcost AdjustmentstoadditionalpaidincapitalWarrantsissuedasfinancingcost	1823450	usd
CY2023	ngtf	Adjustments To Additional Paid In Capital Warrant Dilutive Other Adjustment AdjustmentsToAdditionalPaidInCapitalWarrantDilutiveOtherAdjustment	185669	usd
CY2023	ngtf	Adjustments To Additional Paid In Capital Warrant Dilutive Other Adjustments AdjustmentsToAdditionalPaidInCapitalWarrantDilutiveOtherAdjustments	-64032	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6068384	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-2070262	usd
CY2024	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	16400	usd
CY2024	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	7800	usd
CY2024	ngtf	Common Stock Issued As Financing Cost CommonStockIssuedAsFinancingCost	50000	usd
CY2024	ngtf	Adjustment To Additional Paid In Capital Warrant Issued AdjustmentToAdditionalPaidInCapitalWarrantIssued	84230	usd
CY2024	ngtf	Adjustmentstoadditionalpaidincapital Warrantsissuedasfinancingcost AdjustmentstoadditionalpaidincapitalWarrantsissuedasfinancingcost	721470	usd
CY2024	ngtf	Warrants Issued As Financing Cost Associated With Convertible Notes WarrantsIssuedAsFinancingCostAssociatedWithConvertibleNotes	9878	usd
CY2024	ngtf	Stock Issued During Period Value Business Acquisition StockIssuedDuringPeriodValueBusinessAcquisition	868695	usd
CY2024	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	113955	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-3235506	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-3433327	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-3235506	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6068384	usd
CY2024	ngtf	Noncash Financing Cost Under Contingent Liability NoncashFinancingCostUnderContingentLiability	278200	usd
CY2023	ngtf	Noncash Financing Cost Under Nfn NoncashFinancingCostUnderNFN	57647	usd
CY2023	us-gaap	Other Noncash Expense OtherNoncashExpense	92787	usd
CY2024	us-gaap	Investment Income Interest InvestmentIncomeInterest	17599	usd
CY2024	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	84230	usd
CY2023	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	62850	usd
CY2024	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	7800	usd
CY2023	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	77110	usd
CY2024	ngtf	Stock Issued For Financing Costs StockIssuedForFinancingCosts	50000	usd
CY2023	ngtf	Stock Issued For Financing Costs StockIssuedForFinancingCosts	104515	usd
CY2024	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	638194	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1265893	usd
CY2024	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-111730	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-361500	usd
CY2024	ngtf	Warrants And Returnable Warrants Issued For Financing WarrantsAndReturnableWarrantsIssuedForFinancing	721470	usd
CY2023	ngtf	Warrants And Returnable Warrants Issued For Financing WarrantsAndReturnableWarrantsIssuedForFinancing	1823450	usd
CY2023	ngtf	Financing Cost Due To Conversion Price Adjustments FinancingCostDueToConversionPriceAdjustments	64033	usd
CY2023	ngtf	Consulting Fee Due To Conversion Price Adjustments ConsultingFeeDueToConversionPriceAdjustments	185669	usd
CY2024	us-gaap	Inventory Write Down InventoryWriteDown	4803	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	416701	usd
CY2024	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2054	usd
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4943	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-53928	usd
CY2024	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	14446	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	84002	usd
CY2024	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	45804	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-42070	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	546641	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	403428	usd
CY2024	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	153300	usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	64876	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-709990	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1203995	usd
CY2024	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	149990	usd
CY2024	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	297880	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-447870	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	229729	usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	276066	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	40000	usd
CY2024	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	1252805	usd
CY2023	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	1805800	usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	1375128	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1252805	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	976467	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	94945	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-227528	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53349	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	280877	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	148294	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53349	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	39452	usd
CY2024	ngtf	Warrants And Returnable Warrants Issued For Financing Costs WarrantsAndReturnableWarrantsIssuedForFinancingCosts	721470	usd
CY2024	us-gaap	Stock Issued1 StockIssued1	50000	usd
CY2024	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	686	usd
CY2023	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	6550	usd
CY2024	ngtf	Deemed Dividend Associated With Preferred B Stock And Dilutive Warrant Adjustments DeemedDividendAssociatedWithPreferredBStockAndDilutiveWarrantAdjustments	69181	usd
CY2023	ngtf	Deemed Dividend Associated With Preferred B Stock And Dilutive Warrant Adjustments DeemedDividendAssociatedWithPreferredBStockAndDilutiveWarrantAdjustments	1136946	usd
CY2024	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	171711	usd
CY2023	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	864713	usd
CY2024	ngtf	Preferred Stock C Issued Per Acquisition PreferredStockCIssuedPerAcquisition	868708	usd
CY2024	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	113955	usd
CY2024	ngtf	Principal Increased Under Convertible Note Amended PrincipalIncreasedUnderConvertibleNoteAmended	12500	usd
CY2024	ngtf	Granted Interest Increased Under Convertible Note Amended GrantedInterestIncreasedUnderConvertibleNoteAmended	1875	usd
CY2024	ngtf	Acquisition Cost Under Promissory Note Acquired Under Business Acquisition AcquisitionCostUnderPromissoryNoteAcquiredUnderBusinessAcquisition	126000	usd
CY2023	ngtf	Principal Increased As Financing Cost PrincipalIncreasedAsFinancingCost	57647	usd
CY2023	ngtf	Common Stock Issued To Settle Principal CommonStockIssuedToSettlePrincipal	16088	usd
CY2024	ngtf	Common Stock Issued To Settle Interest Payable CommonStockIssuedToSettleInterestPayable	31250	usd
CY2023	ngtf	Common Stock Issued To Settle Interest Payable CommonStockIssuedToSettleInterestPayable	33907	usd
CY2024	ngtf	Common Stock Issued For Transfer Agent Fee CommonStockIssuedForTransferAgentFee	1750	usd
CY2024	us-gaap	Nature Of Operations NatureOfOperations	<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>1. Description of Business and Going Concern</b></p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nightfood Holdings, Inc. is a Nevada corporation incorporated on -October 16, 2013, to acquire all of the issued and outstanding shares of Nightfood, Inc., a New York corporation from its sole shareholder, Sean Folkson. We are also the sole shareholder of MJ Munchies, Inc., currently revoked in the State of Nevada, which owns certain intellectual property, but does not have any operations as of the period covered by these financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 2, 2024, the Company closed the acquisition of Future Hospitality Ventures Holdings Inc. (“FHVH” or “Future Hospitality”), a Nevada corporation and a new entrant in the Robots-as-a-Service (RaaS) space from Mr. Lei Sonny Wang, who concurrently became the Chief Executive Officer of Nightfood and a member of the Company’s board of directors. Under the leadership of Mr. Wang, as of the time of this filing, Future Hospitality has secured distribution agreements with Next Robot, Inc. (formally Botin Innovations, Inc.) and one other U.S.-based global manufacturer which has not yet been named publicly and is in the process of negotiating and exploring additional supplier relationships. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our corporate address is 520 White Plains Road – Suite 500, Tarrytown, New York 10591 and our telephone number is 866-291-7778. We maintain web sites at www.nightfoodholdings.com, www.nightfood.com, www.RoboOp365.com, along with several additional web properties. Any information that may appear on those web sites should not be deemed to be a part of this report.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company’s fiscal year end is June 30.</p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Going Concern</b></p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in; font-size: 10pt; text-align: justify"> </td> <td style="width: 0.25in; font-size: 10pt; text-align: justify">●</td> <td style="font-size: 10pt; text-align: justify">The Company’s financial statements are prepared using generally accepted accounting principles, which contemplate the realization of assets and liquidation of liabilities in the normal course of business. No certainty of continuation can be stated.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="text-align: justify; width: 24px"> </td> <td style="text-align: justify; width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify; font-size: 10pt">The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern. For the fiscal year ended June 30, 2024, the Company had an operating and net loss of $3,235,506, cash flow used in operations of $709,990 and an accumulated deficit of $38,626,400.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in; text-align: justify"> </td> <td style="width: 0.25in; text-align: justify">●</td> <td style="text-align: justify">The Company has limited available cash resources and we do not believe our cash on hand will be sufficient to fund our operations and growth throughout fiscal year 2025 or adequate to satisfy our immediate or ongoing working capital needs. We are currently in default with respect to the terms of several of our convertible notes payable.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in; text-align: justify"> </td> <td style="width: 0.25in; text-align: justify"> </td> <td style="text-align: justify">The Company is continuing to seek to raise capital through the sales of its common stock, preferred stock and/or convertible notes, as well as potentially the exercise of outstanding warrants, to finance the Company’s operations, of which it can give no assurance of success. Management has devoted a significant amount of time to the raising of capital from additional debt and equity financing. However, the Company’s ability to continue as a going concern is dependent upon raising additional funds through debt and equity financing and generating revenue. Additionally, management is investing in the acquisition of additional revenue generating assets through the issuance of debt and/or equity to further assist the Company’s growth initiatives. As of June 30, 2024 we have advanced proceeds totaling $448,000 to potential targets, which are under negotiation for acquisition as soon as practicable subsequent to June 30, 2024.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in; text-align: justify"> </td> <td style="width: 0.25in; text-align: justify">●</td> <td style="text-align: justify">Because the Company has limited sales, no certainty of continuation can be stated. The Company’s ability to continue as a going concern is dependent upon raising additional funds through debt and equity financing and generating revenue. In addition, the Company will receive the proceeds from its outstanding warrants as, if and when such warrants are exercised for cash. There are no assurances the Company will receive the necessary funding or generate revenue necessary to fund operations.</td></tr> </table> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="text-align: justify; width: 0.25in"> </td> <td style="text-align: justify; width: 0.25in">●</td> <td style="text-align: justify">Even if the Company is successful in raising additional funds, the Company cannot give any assurance that it will, in the future, be able to achieve a level of profitability from the sale of the products and services of its subsidiaries to sustain operations. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on recoverability and reclassification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty.</td></tr> </table>
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-709990	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-38626400	usd
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in; text-align: justify"> </td> <td style="width: 0.25in; text-align: justify">●</td> <td style="text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Estimates are used in the determination of depreciation and amortization, the valuation for non-cash issuances of common stock, and the website, income taxes and contingencies, valuing convertible preferred stock for a “beneficial conversion feature” (“BCF”) and warrants among others.</td></tr> </table>
CY2024	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2024	us-gaap	Inventory Write Down InventoryWriteDown	4803	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	416701	usd
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Concentration of Credit Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash deposits at financial institutions. At various times during the year, the Company may exceed the federally insured limits. To mitigate this risk, the Company places its cash deposits only with high credit quality institutions. Management believes the risk of loss is minimal. At June 30, 2024 and June 30, 2023, the Company did not have any uninsured cash deposits.</p>
CY2024	ngtf	Description Of Beneficial Conversion Feature DescriptionOfBeneficialConversionFeature	(i) 5,000 shares of the Registrant’s common stock (one share for each $0.20 of liquidation preference) (the “Conversion Shares”) and (ii) 5,000 common stock purchase warrants, expiring April 16, 2026 (the “Warrants”). The Warrants carried an initial exercise price of $0.30 per share. Subsequent financing events and debt extinguishment resulted in adjustments to the exercise price of all warrants created from conversion of B Preferred from $0.30 per share to approximately $0.10416 per share through June 30, 2024.
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4400000	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1100000	usd
CY2024	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Reclassification</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="text-align: justify; width: 0.25in"> </td> <td style="text-align: justify; width: 0.25in">●</td> <td style="text-align: justify">The Company may occasionally make certain reclassifications to prior period amounts to conform with the current year’s presentation. Such reclassifications would not have a material effect on its consolidated statement of financial position, results of operations or cash flows.</td></tr> </table>
CY2024Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	111863	usd
CY2024Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther	126000	usd
CY2024Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	4845	usd
CY2024Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther	261852	usd
CY2024Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	-28834	usd
CY2024Q2	us-gaap	Goodwill Goodwill	868708	usd
CY2024Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	897542	usd
CY2024	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	2054	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	4061	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	800	usd
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	11199	usd
CY2024Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	13809	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	25808	usd
CY2024	us-gaap	Inventory Write Down InventoryWriteDown	4803	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	416701	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1206	usd
CY2024Q2	ngtf	Prepaid Professional Fees PrepaidProfessionalFees	72500	usd
CY2024Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	4059	usd
CY2024Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	29396	usd
CY2023Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	92726	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	107161	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	92726	usd
CY2024Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	441479	usd
CY2024Q2	us-gaap	Interest Payable Current InterestPayableCurrent	434535	usd
CY2023Q2	us-gaap	Interest Payable Current InterestPayableCurrent	40779	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	624716	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	553651	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1059251	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	594430	usd
CY2022Q4	ngtf	Convertible Price Per Share ConvertiblePricePerShare	0.2
CY2024Q2	us-gaap	Preferred Units Offering Costs PreferredUnitsOfferingCosts	1000000	usd
CY2024	us-gaap	Noninterest Expense Transfer Agent And Custodian Fees NoninterestExpenseTransferAgentAndCustodianFees	100000	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	5434783	shares
CY2022Q3	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	1086957	shares
CY2024	ngtf	Forbearance Agreement Description ForbearanceAgreementDescription	The Company shall pay to each Purchaser in cash the sum of $482,250.00 for the full and complete satisfaction of the Notes, which includes all due and owing principal, interest and penalties notwithstanding anything to the contrary in the Notes, as follows: (i) $250,000.00 on or before February 7, 2023; (ii) $50,000.00 on or before February 28, 2023; (iii) $50,000.00 on or before March 31, 2023; (iv) $50,000.00 on or before April 30, 2023; and (v) $82,250.00 on or before May 31, 2023.
CY2024	ngtf	Schedule Of Exchange Of Returnable Warrants For Shares Of Common Stock ScheduleOfExchangeOfReturnableWarrantsForSharesOfCommonStock	Below is a reconciliation of the extinguishment of debt relative to the exchange of Returnable Warrants for shares of common stock by the holders:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: justify">3,800,000 shares of common stock issued and exchanged for 10,869,566 returnable warrants</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">342,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Loss on conversion price change in December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,051,801</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Stock settled debt</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,988,402</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Financing charges due to returnable warrants issued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">987,060</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Principal increased due to penalty</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">58,703</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Loss on extinguishment</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">392,459</td><td style="text-align: left"> </td></tr> </table>
CY2024Q2	ngtf	Shares Of Common Stock Issued Returnable Warrants SharesOfCommonStockIssuedReturnableWarrants	3800000	shares
CY2024	ngtf	Shares Of Common Stock Exchanged For Returnable Warrants SharesOfCommonStockExchangedForReturnableWarrants	10869566	shares
CY2024Q2	ngtf	Common Stock Returnable Warrants CommonStockReturnableWarrants	342000	usd
CY2024	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	1051801	shares
CY2024	us-gaap	Restructuring Reserve Settled Without Cash2 RestructuringReserveSettledWithoutCash2	1988402	usd
CY2024Q2	ngtf	Financing Charges Due To Returnable Warrants Issued FinancingChargesDueToReturnableWarrantsIssued	987060	usd
CY2024	ngtf	Under Forbearance Agreement UnderForbearanceAgreement	58703	usd
CY2024	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	392459	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	960197	usd
CY2023	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	93324	usd
CY2023	us-gaap	Interest Costs Incurred InterestCostsIncurred	1053521	usd
	us-gaap	Interest Expense Other InterestExpenseOther	0	usd
CY2023	us-gaap	Interest Expense Other InterestExpenseOther	0	usd
CY2024	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	604800	usd
CY2023Q2	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	49995	usd
CY2023Q2	us-gaap	Stock Issued1 StockIssued1	16088	usd
CY2023Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	33907	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.1
CY2023Q1	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	7000000	shares
CY2023Q1	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	136800	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1790000	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.1
CY2023Q1	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	1820000	shares
CY2024Q2	us-gaap	Noninterest Expense Transfer Agent And Custodian Fees NoninterestExpenseTransferAgentAndCustodianFees	1750	usd
CY2024Q2	us-gaap	Common Unit Issued CommonUnitIssued	1000000	shares
CY2024	ngtf	Fair Market Value Of Common Stock FairMarketValueOfCommonStock	1000000	shares
CY2024	us-gaap	Equity Fair Value Adjustment EquityFairValueAdjustment	16400	usd
CY2024	us-gaap	Interest Expense Other InterestExpenseOther	31250	usd
CY2024	us-gaap	Legal Fees LegalFees	1750	usd
CY2024	ngtf	Extinguishment Of Debt Gain Loss Gross Of Tax ExtinguishmentOfDebtGainLossGrossOfTax	-33000	usd
CY2024	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	-16600	usd
CY2023Q1	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	136800	usd
CY2023Q1	ngtf	Purchase Issue Amount PurchaseIssueAmount	24141	usd
CY2023Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1790000	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.1
CY2023Q2	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	1820000	shares
CY2024	ngtf	Warrants To Purchase Shares WarrantsToPurchaseShares	57000	shares
CY2024Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.1
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	169941	usd
CY2023Q2	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	136800	usd
CY2023Q2	ngtf	Purchase Issue Amount PurchaseIssueAmount	24141	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1790000	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.1
CY2023Q1	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	1820000	shares
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	200000	usd
CY2023Q2	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	170000	usd
CY2023Q2	ngtf	Purchase Issue Amount PurchaseIssueAmount	30000	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	62000	usd
CY2023Q4	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	52700	usd
CY2023Q4	us-gaap	Short Duration Contracts Discounted Liabilities Amount ShortDurationContractsDiscountedLiabilitiesAmount	9300	usd
CY2023Q4	us-gaap	Common Stock Convertible Conversion Price Increase CommonStockConvertibleConversionPriceIncrease	0.033
CY2023Q4	us-gaap	Prepayment Fees On Advances Net PrepaymentFeesOnAdvancesNet	750	usd
CY2023Q4	ngtf	Outstanding Principal Amount Percentage OutstandingPrincipalAmountPercentage	0.50	pure
CY2023Q4	ngtf	Repayment Repayment	1.50	pure
CY2023Q4	ngtf	Cash Fee CashFee	5270	usd
CY2023Q4	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	159697	shares
CY2023Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	0.033
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	62000	usd
CY2023Q4	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	52700	usd
CY2023Q4	ngtf	Discount Issue DiscountIssue	9300	usd
CY2023Q4	ngtf	Cash Fee CashFee	5270	usd
CY2023Q4	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	159697	shares
CY2023Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	0.033
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	170588	usd
CY2023Q4	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	145000	usd
CY2023Q4	ngtf	Discount Issue DiscountIssue	25588	usd
CY2023Q4	ngtf	Cash Fee CashFee	14500	usd
CY2023Q4	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	439394	shares
CY2023Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	0.033
CY2024Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	388300	usd
CY2024Q1	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	330055	usd
CY2024Q1	ngtf	Discount Issue DiscountIssue	58245	usd
CY2024Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	336000	usd
CY2024Q1	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	285600	usd
CY2024Q1	ngtf	Discount Issue DiscountIssue	50400	usd
CY2024Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	395000	usd
CY2024Q2	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	335750	usd
CY2024Q2	ngtf	Purchase Issue Amount PurchaseIssueAmount	59250	usd
CY2024Q2	ngtf	Conversion Amount ConversionAmount	1750	usd
CY2023Q2	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	55250	usd
CY2023Q2	ngtf	Purchase Issue Amount PurchaseIssueAmount	9750	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	600000	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.1
CY2023Q2	ngtf	Common Stock As Commitment Shares CommonStockAsCommitmentShares	1477272	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	650000	shares
CY2024	ngtf	Cash Fee CashFee	5100	usd
CY2024	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	650000	shares
CY2024	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	0.033
CY2024Q1	us-gaap	Line Of Credit Facility Annual Principal Payment LineOfCreditFacilityAnnualPrincipalPayment	65000	usd
CY2024Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	434535	usd
CY2023Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	40779	usd
CY2024Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.03333
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024	ngtf	Outstanding Share In Percentage OutstandingShareInPercentage	0.50	pure
CY2022Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	5000000	shares
CY2024Q2	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	31250	usd
CY2024	ngtf	Transfer Agent Fee TransferAgentFee	1750	usd
CY2024Q2	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	16400	usd
CY2023	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	467950	shares
CY2023Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.5
CY2023Q2	us-gaap	Common Unit Issued CommonUnitIssued	1871800	shares
CY2023	ngtf	Issued Stock Purchase Warrants IssuedStockPurchaseWarrants	5750000	shares
CY2023Q2	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	16088	usd
CY2023Q2	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	33907	usd
CY2023Q2	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	91500	usd
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1000	shares
CY2022	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	335	shares
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	335000	usd
CY2024Q2	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	5000	shares
CY2024	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	4431387	usd
CY2024	us-gaap	Preferred Stock Amount Of Preferred Dividends In Arrears PreferredStockAmountOfPreferredDividendsInArrears	84106	usd
CY2023	us-gaap	Preferred Stock Amount Of Preferred Dividends In Arrears PreferredStockAmountOfPreferredDividendsInArrears	1136946	usd
CY2022Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	4000000	shares
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.25
CY2023	us-gaap	Subsidiary Or Equity Method Investee Cumulative Number Of Shares Issued For All Transactions SubsidiaryOrEquityMethodInvesteeCumulativeNumberOfSharesIssuedForAllTransactions	12870000	shares
CY2023	ngtf	Aggregate Common Stock Shares AggregateCommonStockShares	5750000	shares
CY2023	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.05
CY2023	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	276066	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	377560	usd
CY2024Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	650000	shares
CY2024	ngtf	Additional Financing Costs In Cumulative Amount AdditionalFinancingCostsInCumulativeAmount	699350	usd
CY2024Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	28557967	shares
CY2024	ngtf	Stock Purchase Warrants StockPurchaseWarrants	1818182	shares
CY2024	ngtf	Warrant Description WarrantDescription	Certain warrants in the below table include dilution protection for the warrant holders, which could cause the exercise price to be adjusted either higher or lower as a result of various financing events and stock transactions. The result of the warrant exercise price downward adjustment on modification date is treated as a deemed dividend and fully amortized on the transaction date. In addition to the reduction in exercise price, with certain warrants there is a corresponding increase to the number of warrants to the holder on a prorated basis. Under certain conditions, such as the successful retirement of a convertible note through repayment, it is possible for the exercise price of these warrants to increase and for the number of warrants outstanding to decrease.
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	6140000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	4220000	usd
CY2023Q3	ngtf	Non Refundable Warrants Issued NonRefundableWarrantsIssued	4800000	shares
CY2023Q3	ngtf	Warrants To Purchase Shares WarrantsToPurchaseShares	4800000	shares
CY2023Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.0333
CY2023Q3	us-gaap	Financing Receivable Percent Past Due1 FinancingReceivablePercentPastDue1	0.10	pure
CY2023Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	173195	usd
CY2023Q3	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	126065	usd
CY2023Q3	ngtf	Issued Stock Purchase Warrants IssuedStockPurchaseWarrants	5248344	shares
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	299260	usd
CY2024Q2	ngtf	Cash Performance Rate CashPerformanceRate	0.02	pure
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.10	pure
CY2024	ngtf	Average Closing Priced Trading Days AverageClosingPricedTradingDays	10	pure
CY2024	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	42500	usd
CY2024Q2	us-gaap	Class Of Warrant Or Right Unissued ClassOfWarrantOrRightUnissued	2111280	shares
CY2024	us-gaap	Related Party Tax Expense Due To Affiliates Current RelatedPartyTaxExpenseDueToAffiliatesCurrent	295510	usd
CY2023	us-gaap	Related Party Tax Expense Due To Affiliates Current RelatedPartyTaxExpenseDueToAffiliatesCurrent	101876	usd
CY2024Q2	us-gaap	Principal Amount Outstanding On Loans Securitized PrincipalAmountOutstandingOnLoansSecuritized	40000	usd
CY2024	ngtf	Services Fees Related Parties ServicesFeesRelatedParties	234500	usd
CY2023	ngtf	Services Fees Related Parties ServicesFeesRelatedParties	150500	usd
CY2024Q2	us-gaap	Common Stock Other Value Outstanding CommonStockOtherValueOutstanding	500000	usd
CY2024	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	6000	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.10	pure
CY2024	ngtf	Percentage Of Cash Bonus PercentageOfCashBonus	0.10	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.065	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.065	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.206	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.119	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.351	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.264	pure
CY2024	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2024Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5825004	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4960443	usd
CY2024Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5825004	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4960443	usd
CY2024	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	26590000	usd
CY2024Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	2614000	usd
CY2024Q2	us-gaap	Tax Credit Carryforward Valuation Allowance TaxCreditCarryforwardValuationAllowance	1100000	usd
CY2024	ngtf	Ownership Term OwnershipTerm	P3Y
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53349	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	29335	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	92726	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	175410	usd
CY2023Q2	us-gaap	Assets Assets	175410	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	594430	usd
CY2023Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1549366	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2245672	usd
CY2023Q2	us-gaap	Liabilities Liabilities	2245672	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	123587968	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	123587968	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	123588	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	33112935	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-35306788	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-2070262	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	175410	usd
CY2023	us-gaap	Revenues Revenues	133406	usd
CY2023	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	277843	usd
CY2023	ngtf	Advertising And Promotional AdvertisingAndPromotional	144859	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	838413	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	941240	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	2202355	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-2068949	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	172769	usd
CY2023	ngtf	Interest Expense Financing Cost InterestExpenseFinancingCost	2199273	usd
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1265893	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-361500	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3999435	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6068384	usd
CY2023Q2	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	65000	usd
CY2023Q3	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	60000	usd
CY2024Q2	us-gaap	Investment Maturity Date InvestmentMaturityDate	2025-01-23
CY2024Q3	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	335750	usd
CY2024	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024	dei	Auditor Firm AuditorFirmId	5525
CY2023Q2	us-gaap	Inventory Net InventoryNet		usd
CY2023Q2	ngtf	Acquisition Costs Secured By Promissory Note AcquisitionCostsSecuredByPromissoryNote		usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill		usd
CY2023	us-gaap	Interest Income Other InterestIncomeOther		usd
CY2023	ngtf	Stock Issued During Period Value Common Stock From Conversion StockIssuedDuringPeriodValueCommonStockFromConversion		usd
CY2023	ngtf	Stock Issued During Period Values Conversion Of Convertible Securities StockIssuedDuringPeriodValuesConversionOfConvertibleSecurities		usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings		usd
CY2024	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2024	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings		usd
CY2023	ngtf	Noncash Financing Cost Under Contingent Liability NoncashFinancingCostUnderContingentLiability		usd
CY2024	ngtf	Noncash Financing Cost Under Nfn NoncashFinancingCostUnderNFN		usd
CY2024	us-gaap	Other Noncash Expense OtherNoncashExpense		usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest		usd
CY2024	ngtf	Financing Cost Due To Conversion Price Adjustments FinancingCostDueToConversionPriceAdjustments		usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
CY2023	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable		usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2024	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2024	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2024	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2024	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
CY2024	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2024	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023	ngtf	Warrants And Returnable Warrants Issued For Financing Costs WarrantsAndReturnableWarrantsIssuedForFinancingCosts		usd
CY2023	us-gaap	Stock Issued1 StockIssued1		usd
CY2023	ngtf	Preferred Stock C Issued Per Acquisition PreferredStockCIssuedPerAcquisition		usd
CY2023	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1		usd
CY2023	ngtf	Principal Increased Under Convertible Note Amended PrincipalIncreasedUnderConvertibleNoteAmended		usd
CY2023	ngtf	Granted Interest Increased Under Convertible Note Amended GrantedInterestIncreasedUnderConvertibleNoteAmended		usd
CY2023	ngtf	Acquisition Cost Under Promissory Note Acquired Under Business Acquisition AcquisitionCostUnderPromissoryNoteAcquiredUnderBusinessAcquisition		usd
CY2024	ngtf	Principal Increased As Financing Cost PrincipalIncreasedAsFinancingCost		usd
CY2024	ngtf	Common Stock Issued To Settle Principal CommonStockIssuedToSettlePrincipal		usd
CY2023	ngtf	Common Stock Issued For Transfer Agent Fee CommonStockIssuedForTransferAgentFee		usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods		usd
CY2023Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials		usd
CY2023Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess		usd
CY2023Q2	us-gaap	Inventory Net InventoryNet		usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent		usd
CY2023Q2	ngtf	Prepaid Professional Fees PrepaidProfessionalFees		usd
CY2023Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent		usd
CY2024	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
CY2024	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
CY2024	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization		usd
CY2024	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization		usd
CY2024	us-gaap	Interest Costs Incurred InterestCostsIncurred		usd
CY2024	us-gaap	Interest Costs Incurred InterestCostsIncurred		usd
CY2024	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock		usd
CY2024Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross		usd
CY2023Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross		usd
CY2023Q2	us-gaap	Inventory Net InventoryNet		usd
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0001593001
CY2024	dei	No Trading Symbol Flag NoTradingSymbolFlag	true
CY2024	dei	Security Exchange Name SecurityExchangeName	NONE

Files In Submission

Name	View Source	Status
0001213900-24-113166-index-headers.html	Edgar Link	pending
0001213900-24-113166-index.html	Edgar Link	pending
0001213900-24-113166.txt	Edgar Link	pending
0001213900-24-113166-xbrl.zip	Edgar Link	pending
ea0221060-10k_nightfood.htm	Edgar Link	pending
ea022106001ex10-19_nightfood.htm	Edgar Link	pending
ea022106001ex10-21_nightfood.htm	Edgar Link	pending
ea022106001ex10-22_nightfood.htm	Edgar Link	pending
ea022106001ex21_nightfood.htm	Edgar Link	pending
ea022106001ex31-1_nightfood.htm	Edgar Link	pending
ea022106001ex32-1_nightfood.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
ngtf-20240630.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
ngtf-20240630_cal.xml	Edgar Link	unprocessable
ngtf-20240630_def.xml	Edgar Link	unprocessable
ngtf-20240630_lab.xml	Edgar Link	unprocessable
ngtf-20240630_pre.xml	Edgar Link	unprocessable
ea0221060-10k_nightfood_htm.xml	Edgar Link	completed
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NGTF
NightFood Holdings, Inc. Stock $ngtf

2024 Q4 Form 10-K Financial Statement

#000121390024113166 Filed on December 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NGTF NightFood Holdings, Inc. Stock $ngtf

2024 Q4 Form 10-K Financial Statement

#000121390024113166 Filed on December 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NGTF
NightFood Holdings, Inc. Stock $ngtf